AMNEAL PHARMACEUTICALS INC's ticker is AMRX and the CUSIP is 03168L105. A total of 157 filers reported holding AMNEAL PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.77 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $106,555 | +29.0% | 25,250 | -5.3% | 0.00% | 0.0% |
| Q2 2023 | $82,615 | +123.0% | 26,650 | 0.0% | 0.00% | – |
| Q1 2023 | $37,043 | -31.8% | 26,650 | -2.4% | 0.00% | – |
| Q4 2022 | $54,343 | -99.9% | 27,308 | -47.2% | 0.00% | -100.0% |
| Q3 2022 | $52,052,000 | +61866.7% | 51,674 | +95.1% | 0.00% | 0.0% |
| Q2 2022 | $84,000 | -21.5% | 26,486 | +3.2% | 0.00% | 0.0% |
| Q1 2022 | $107,000 | -12.3% | 25,672 | +1.2% | 0.00% | 0.0% |
| Q4 2021 | $122,000 | -15.3% | 25,373 | -5.6% | 0.00% | 0.0% |
| Q3 2021 | $144,000 | – | 26,884 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fosun International Ltd | 21,521,301 | $83,503,000 | 7.34% |
| Eversept Partners, LP | 2,656,208 | $10,306,087 | 2.29% |
| TPG Group Holdings (SBS) Advisors, Inc. | 16,213,367 | $62,908,000 | 1.13% |
| Prosight Management, LP | 512,659 | $1,989,000 | 0.95% |
| THB ASSET MANAGEMENT | 833,104 | $3,232,000 | 0.90% |
| GLOBEFLEX CAPITAL L P | 251,696 | $977,000 | 0.26% |
| XTX MARKETS LLC | 10,243 | $40,000 | 0.19% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 102,000 | $396,000 | 0.10% |
| PA Capital LLC | 33,874 | $132,000 | 0.09% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 60,900 | $236,000 | 0.07% |